Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.

Blood
Nghia T V Le, Des R Richardson

Abstract

Iron (Fe) is critical for proliferation, but its precise role in cell cycle progression remains unclear. In this study, we examined the mechanisms involved by assessing the effects of Fe chelators on the expression of molecules that play key roles in this process. In initial studies, gene arrays were used to assess gene expression after incubating cells with 2 Fe chelators, namely, desferrioxamine (DFO) and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (311), or the DNA-damaging agent, actinomycin D. From the genes assessed, only the N-myc downstream-regulated gene 1 (Ndrg1) was specifically up-regulated by Fe chelation. Although the function of Ndrg1 is unclear, previous studies showed it markedly slows tumor growth and acts as a potent metastasis suppressor. Incubation of cells with chelators markedly increased Ndrg1 mRNA and protein expression, but this was not found with their Fe complexes or when the Fe-binding site had been inactivated. Increased Ndrg1 expression following Fe chelation was related to the permeability and antiproliferative activity of chelators and could be reversed by Fe repletion. Moreover, Ndrg1 up-regulation after chelation occurred at the transcriptional level and was mediated by hypoxia induci...Continue Reading

References

Jan 1, 1979·Journal of Supramolecular Structure·J W Larrick, P Cresswell
Jan 1, 1979·Annual Review of Biochemistry·L Thelander, P Reichard
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G L SemenzaS E Antonarakis
Jun 12, 1990·Biochimica Et Biophysica Acta·D R Richardson, E Baker
May 1, 1987·European Journal of Pediatrics·J BlattP A Lee
Dec 8, 1995·The Journal of Biological Chemistry·C SeiserL C Kühn
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A DonfrancescoG Deb
Jul 17, 1995·Biochemical and Biophysical Research Communications·G L WangG L Semenza
Aug 15, 1994·FEBS Letters·K FukuchiK Gomi
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·T M Lin, C Chang
Mar 14, 1997·Biochimica Et Biophysica Acta·D R Richardson, P Ponka
Dec 5, 1998·Free Radical Biology & Medicine·C C ChuaB H Chua
Aug 10, 1999·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·D R Richardson, P V Bernhardt
Dec 23, 1999·The New England Journal of Medicine·N C Andrews
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·A ChabesL Thelander
Apr 11, 2000·Molecular and Cellular Biology·M AshcroftK H Vousden
Sep 28, 2000·Biochemical and Biophysical Research Communications·H ParkC H Graham
Mar 20, 2002·Biochimie·D P Guimaraes, P Hainaut
Mar 22, 2002·British Journal of Pharmacology·Anthony KicicErica Baker
Sep 21, 2002·Biochimica Et Biophysica Acta·Nghia T V Le, Des R Richardson
Dec 17, 2002·Molecular and Cellular Biology·Nobuhito GodaRandall S Johnson
Feb 8, 2003·Advances in Experimental Medicine and Biology·Joan L BussPrem Ponka

❮ Previous
Next ❯

Citations

Jun 1, 2005·Biochemical and Biophysical Research Communications·Michael HunterLuba Kalaydjieva
Mar 19, 2011·Cell Death and Differentiation·P N Kelly, A Strasser
Jul 23, 2013·Cellular & Molecular Immunology·Tanapat PalagaPatipark Kueanjinda
Feb 27, 2009·Nature Reviews. Cancer·Steven Christopher Smith, Dan Theodorescu
Feb 14, 2006·Cell Research·Mark F van Delft, David C S Huang
Oct 22, 2005·Leukemia·N W C J van de DonkA C Bloem
Aug 8, 2006·Oncogene·M FontenayE Solary
Jul 27, 2007·Oncogene·K PodarK C Anderson
Sep 12, 2008·Bioinformatics·Justin Klekota, Frederick P Roth
Jul 10, 2008·Journal of the National Cancer Institute·Leo R ZacharskiPhilip W Lavori
Dec 17, 2009·Hematology·Heather A Leitch, Linda M Vickars
Jun 3, 2008·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Julija Matijević-SosaBlazenka Jurisić
Jul 28, 2013·Nutrients·Jessica L HeathDaniel S Wechsler
Sep 1, 2009·Future Medicinal Chemistry·Danuta S KalinowskiDes R Richardson
Jul 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Megan WhitnallDes R Richardson
Sep 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Megan WhitnallDes R Richardson
Aug 12, 2014·Trends in Pharmacological Sciences·Agnieszka GórskaMichał Piotr Marszałł
Feb 5, 2016·Biochimica Et Biophysica Acta·Danuta S KalinowskiDes R Richardson
Jul 30, 2005·Expert Opinion on Investigational Drugs·H Lennart Persson, Des R Richardson
Dec 27, 2005·Cancer Investigation·Paula M B Pahl, Lawrence D Horwitz
Sep 24, 2015·International Journal of Oncology·Tomohiro KurokawaNobuhiro Ohkohchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.